CABAZITAXEL (CBZ) plus PREDNISONE (P; CBZP) IN PATIENTS (PTS) WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) PREVIOUSLY TREATED WITH DOCETAXEL (D): INTERIM RESULTS FROM COMPASSIONATE-USE PROGRAMME (CUP) AND EARLY-ACCESS PROGRAMME (EAP)
Author
Heidenreich, A.
Parente, P.
de Schultz, W.
Gerritsen, W. R.
Anton Aparicio, L. M.
Malik, Z. I.
Di Lorenzo, G.
Basaran, M.
Hitier, S.
Bahl, A.
Metadata
Show full item recordCollections
- Bildiri [64839]